Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 141 AUD 7.15% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Pro Medicus Ltd?
Write Note

Profitability Summary

Pro Medicus Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Pro Medicus Ltd

Revenue
146.2m AUD
Cost of Revenue
-430k AUD
Gross Profit
145.8m AUD
Operating Expenses
-45.5m AUD
Operating Income
100.3m AUD
Other Expenses
-30.6m AUD
Net Income
69.7m AUD

Margins Comparison
Pro Medicus Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Pro Medicus Ltd
ASX:PME
14.7B AUD
100%
69%
48%
US
Cerner Corp
LSE:0R00
31.3B USD
83%
13%
10%
US
Veeva Systems Inc
NYSE:VEEV
30.7B USD
72%
21%
22%
US
Doximity Inc
NYSE:DOCS
6.5B USD
90%
37%
33%
US
Inspire Medical Systems Inc
NYSE:INSP
5.7B USD
85%
-2%
1%
JP
M3 Inc
TSE:2413
791.1B JPY
58%
25%
18%
SE
Sectra AB
STO:SECT B
46.6B SEK
47%
-41%
25%
US
Waystar Holding Corp
NASDAQ:WAY
4.1B USD
68%
18%
-6%
US
Evolent Health Inc
NYSE:EVH
3B USD
19%
0%
-5%
US
Vocera Communications Inc
F:V00
2.4B EUR
66%
0%
-4%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.5B USD
92%
-4%
-8%
Country AU
Market Cap 14.7B AUD
Gross Margin
100%
Operating Margin
69%
Net Margin
48%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Operating Margin
13%
Net Margin
10%
Country US
Market Cap 30.7B USD
Gross Margin
72%
Operating Margin
21%
Net Margin
22%
Country US
Market Cap 6.5B USD
Gross Margin
90%
Operating Margin
37%
Net Margin
33%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Operating Margin
-2%
Net Margin
1%
Country JP
Market Cap 791.1B JPY
Gross Margin
58%
Operating Margin
25%
Net Margin
18%
Country SE
Market Cap 46.6B SEK
Gross Margin
47%
Operating Margin
-41%
Net Margin
25%
Country US
Market Cap 4.1B USD
Gross Margin
68%
Operating Margin
18%
Net Margin
-6%
Country US
Market Cap 3B USD
Gross Margin
19%
Operating Margin
0%
Net Margin
-5%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Operating Margin
0%
Net Margin
-4%
Country US
Market Cap 2.5B USD
Gross Margin
92%
Operating Margin
-4%
Net Margin
-8%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Pro Medicus Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Pro Medicus Ltd
ASX:PME
14.7B AUD
50%
36%
59%
87%
US
Cerner Corp
LSE:0R00
31.3B USD
14%
8%
12%
10%
US
Veeva Systems Inc
NYSE:VEEV
30.7B USD
13%
10%
12%
30%
US
Doximity Inc
NYSE:DOCS
6.5B USD
17%
14%
18%
47%
US
Inspire Medical Systems Inc
NYSE:INSP
5.7B USD
1%
1%
-2%
-6%
JP
M3 Inc
TSE:2413
791.1B JPY
13%
9%
15%
16%
SE
Sectra AB
STO:SECT B
46.6B SEK
30%
14%
-48%
-27%
US
Waystar Holding Corp
NASDAQ:WAY
4.1B USD
-3%
-1%
3%
3%
US
Evolent Health Inc
NYSE:EVH
3B USD
-8%
-4%
0%
0%
US
Vocera Communications Inc
F:V00
2.4B EUR
-5%
-2%
0%
0%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.5B USD
-8%
-4%
-2%
-3%
Country AU
Market Cap 14.7B AUD
ROE
50%
ROA
36%
ROCE
59%
ROIC
87%
Country US
Market Cap 31.3B USD
ROE
14%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 30.7B USD
ROE
13%
ROA
10%
ROCE
12%
ROIC
30%
Country US
Market Cap 6.5B USD
ROE
17%
ROA
14%
ROCE
18%
ROIC
47%
Country US
Market Cap 5.7B USD
ROE
1%
ROA
1%
ROCE
-2%
ROIC
-6%
Country JP
Market Cap 791.1B JPY
ROE
13%
ROA
9%
ROCE
15%
ROIC
16%
Country SE
Market Cap 46.6B SEK
ROE
30%
ROA
14%
ROCE
-48%
ROIC
-27%
Country US
Market Cap 4.1B USD
ROE
-3%
ROA
-1%
ROCE
3%
ROIC
3%
Country US
Market Cap 3B USD
ROE
-8%
ROA
-4%
ROCE
0%
ROIC
0%
Country US
Market Cap 2.4B EUR
ROE
-5%
ROA
-2%
ROCE
0%
ROIC
0%
Country US
Market Cap 2.5B USD
ROE
-8%
ROA
-4%
ROCE
-2%
ROIC
-3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top